Literature DB >> 19345348

Dehydroepiandrosterone treatment of ovarian failure.

David H Barad, Andrea Weghofer, Norbert Gleicher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19345348     DOI： 10.1016/j.fertnstert.2008.12.134

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  3 in total

1.  Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation.

Authors:  Antonina I Frolova; Kathleen O'Neill; Kelle H Moley
Journal:  Mol Endocrinol       Date:  2011-06-16

Review 2.  Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).

Authors:  Norbert Gleicher; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-05-17       Impact factor: 5.211

3.  Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial.

Authors:  Huan H Zhang; Ping Y Xu; Juan Wu; Wei W Zou; Xia M Xu; Xia Y Cao; Lian Z Wei
Journal:  J Ovarian Res       Date:  2014-10-21       Impact factor: 4.234
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.